Physician profile
Rex E Luttrell
NPI 1477559680
$4,918.84
in general payments reported to CMS, 2019-2025
26 companies · $93.95 in 2025
The $93.95 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,675 · 2020: $427 · 2021: $637 · 2022: $336 · 2023: $403 · 2024: $346 · 2025: $93.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $843.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $843.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $2,956.89 | 2019-2025 | Gore Synecor Biomaterial |
| Apollo Endosurgery US INC | $436.08 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Novo Nordisk INC | $305.46 | 2019-2024 | Wegovy, Saxenda |
| Ethicon US, LLC | $227.85 | 2019-2024 | Echelon Circular, Echelon; Endopath, Stratafix |
| Reshape Lifesciences INC. | $175.32 | 2019-2023 | |
| Baudax Bio INC. | $147.01 | 2020-2022 | |
| Merz North America, INC. | $117.82 | 2019 | |
| Kerecis Limited | $76.72 | 2021 | |
| Innovation Technologies INC | $49.14 | 2022-2024 | Irrisept |
| Kci USA, INC. | $47.79 | 2022-2023 | V.A.C. Dermatac, V.A.C. Veraflo, Activ.A.C. |
| Baxter Healthcare | $46.42 | 2019 | |
| Tela Bio, INC. | $45.34 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Intuitive Surgical, INC. | $45.12 | 2019 | |
| Smith+Nephew, INC. | $35.79 | 2019-2021 | |
| Davol INC. | $26.00 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $20.39 | 2022 | |
| Solventum Corporation | $20.08 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Glaxosmithkline, LLC. | $19.63 | 2020 | |
| Phathom Pharmaceuticals, INC. | $18.94 | 2024 | Voquezna |
| Integra Lifesciences Corporation | $17.14 | 2019 | |
| Paratek Pharmaceuticals, INC. | $15.95 | 2020 | |
| Teleflex LLC | $15.42 | 2022 | |
| Endo Pharmaceuticals INC. | $14.34 | 2021 | |
| Currax Pharmaceuticals LLC | $13.50 | 2022 | |
| Lilly USA, LLC | $12.74 | 2023 | Zepbound |
| Acera Surgical, INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Luttrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.